PT1077068E - Utilizacao do interferao alfa 5 no tratamento de hepatopatias virais - Google Patents

Utilizacao do interferao alfa 5 no tratamento de hepatopatias virais

Info

Publication number
PT1077068E
PT1077068E PT99919282T PT99919282T PT1077068E PT 1077068 E PT1077068 E PT 1077068E PT 99919282 T PT99919282 T PT 99919282T PT 99919282 T PT99919282 T PT 99919282T PT 1077068 E PT1077068 E PT 1077068E
Authority
PT
Portugal
Prior art keywords
livers
alpha
treatment
sub
type
Prior art date
Application number
PT99919282T
Other languages
English (en)
Inventor
Jesus Prieto Valtuena
M Pilar Civeira Murillo
Esther Larrea Leoz
Original Assignee
Fundacion Para La Invest Medic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Para La Invest Medic filed Critical Fundacion Para La Invest Medic
Publication of PT1077068E publication Critical patent/PT1077068E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PT99919282T 1998-05-13 1999-05-13 Utilizacao do interferao alfa 5 no tratamento de hepatopatias virais PT1077068E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801003A ES2138565B1 (es) 1998-05-13 1998-05-13 Uso del interferon alfa 5 en el tratamiento de las hepatopatias viral es.

Publications (1)

Publication Number Publication Date
PT1077068E true PT1077068E (pt) 2002-07-31

Family

ID=8303773

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99919282T PT1077068E (pt) 1998-05-13 1999-05-13 Utilizacao do interferao alfa 5 no tratamento de hepatopatias virais

Country Status (15)

Country Link
US (2) US6995133B1 (pt)
EP (1) EP1077068B9 (pt)
JP (1) JP2002514606A (pt)
CN (1) CN1173738C (pt)
AT (1) ATE214941T1 (pt)
AU (1) AU753463B2 (pt)
BR (1) BR9911774A (pt)
CA (1) CA2335645C (pt)
DE (2) DE69901099T4 (pt)
DK (1) DK1077068T5 (pt)
ES (2) ES2138565B1 (pt)
PT (1) PT1077068E (pt)
RU (1) RU2209079C2 (pt)
SE (1) SE1077068T5 (pt)
WO (1) WO1999058143A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110179530A1 (en) * 2001-01-23 2011-07-21 University Of Central Florida Research Foundation, Inc. Pharmaceutical Proteins, Human Therapeutics, Human Serum Albumin Insulin, Native Cholera Toxin B Subunit on Transgenic Plastids
FR2824333B1 (fr) * 2001-05-03 2003-08-08 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 5
ES2303492A1 (es) * 2004-08-18 2008-08-01 Instituto Cientifico Y Tecnologico De Navarra S.A. Uso del factor de crecimiento semejante a la insulina tipo i y de interferon alfa en el tratamiento de una enfermedad hepatica cronica, kit y composiciones que los comprenden.
WO2006032711A1 (es) * 2004-08-18 2006-03-30 Instituto Científico Y Tecnológico De Navarra S.A. Uso del factor de crecimiento semejante a la insulina tipo i y de interferón alfa en el tratamiento de una enfermedad hepática crónica, kit y composiciones que los comprenden
KR101858598B1 (ko) 2010-02-01 2018-05-16 디그나 비오테크, 에스.엘. 인터페론 알파 5의 제조방법
CN103732242A (zh) * 2011-06-23 2014-04-16 迪格纳生物技术公司 用与IFN-α2b组合的IFN-α5在患者群体中治疗慢性丙型肝炎
LT6164B (lt) 2013-10-15 2015-06-25 Uab Biotechnologinės Farmacijos Centras "Biotechpharma" Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US5547853A (en) * 1991-03-12 1996-08-20 Biogen, Inc. CD2-binding domain of lymphocyte function associated antigen 3
EP0741577B1 (en) * 1994-03-07 2002-11-06 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection

Also Published As

Publication number Publication date
BR9911774A (pt) 2001-02-06
ES2174604T3 (es) 2002-11-01
EP1077068B1 (en) 2002-03-27
SE1077068T3 (sv) 2002-07-02
WO1999058143A1 (es) 1999-11-18
JP2002514606A (ja) 2002-05-21
CA2335645A1 (en) 1999-11-18
ATE214941T1 (de) 2002-04-15
US7501392B2 (en) 2009-03-10
EP1077068B9 (en) 2002-10-02
DE69901099D1 (de) 2002-05-02
AU753463B2 (en) 2002-10-17
EP1077068A1 (en) 2001-02-21
CN1307482A (zh) 2001-08-08
DE69901099T4 (de) 2003-03-13
DK1077068T5 (da) 2002-10-14
ES2138565B1 (es) 2000-08-16
ES2138565A1 (es) 2000-01-01
AU3711199A (en) 1999-11-29
US6995133B1 (en) 2006-02-07
DK1077068T3 (da) 2002-07-22
SE1077068T5 (sv) 2003-03-04
WO1999058143A9 (es) 2002-08-22
US20060188477A1 (en) 2006-08-24
RU2209079C2 (ru) 2003-07-27
DE69901099T2 (de) 2002-11-07
CN1173738C (zh) 2004-11-03
CA2335645C (en) 2011-01-04

Similar Documents

Publication Publication Date Title
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
IL210455A0 (en) Novel cytokine zcytor17 ligand
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
ATE263778T1 (de) Niedrigallergene proteinvarianten
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
BR0111562A (pt) Análogos de peptìdeo 1 semelhantes ao glucagon
GB9110874D0 (en) Medicaments
KR0156587B1 (en) Composition for therapeutic agent against chronic viral hepatic disease
DE60237791D1 (de) Zytokinproteinfamilie
PT1077068E (pt) Utilizacao do interferao alfa 5 no tratamento de hepatopatias virais
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
FI981381A (fi) Menetelmä HCV-polypeptidien valmistamiseksi
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
IT1270941B (it) Peptidi di hcv e loro usi.
ES2143918A1 (es) Peptidos inhibidores de la proteasa c y su utilizacion en la preparacion de composiciones utiles en las infecciones causadas por el virus de la hepatitis c.
TH7280EX (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
ATE459708T1 (de) Herstellung von infektiöser respiratorischer synzitial virus aus klonierten nukleotid sequenzen
DK293790A (da) Fremgangsmaade og sammensaetninger til behandling af pattedyrsinfektioner under anvendelse af praeparater omfattende gift fra hymenoptera, proteinagtige komponenter eller polypeptidkomponenter heraf eller analoger til disse proteinagtige komponenter eller polypeptidkomponenter